According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -HK$3.87 B. In 2023 the company made an earning of -HK$2.82 B a decrease over its 2022 earnings that were of -HK$2.28 B.The earnings displayed on this page is the company's Pretax Income.